The FDA announced on 2014-10-16 that Hospira Inc. voluntarily recalled Lidocaine HCl Injection Vials due to particulate matter hazards. The recall affects 100,100 units distributed nationwide.
How to tell if you have it
- Brand: Hospira
- Product: 1% LIDOCAINE HCl Injection, USP, 10 mg/mL, 30 mL Single-dose, Preservative-Free glass vial
- NDC: 0409-4279-02
- Lot#: 40-316-DK
- Expiration Date: Exp 01APR2016
The hazard
A returned customer sample was evaluated and found to have human hair attached to a pinched area of the stopper, according to the FDA.
Context
GovInfoNow's records show Hospira Inc. has 108 other recalls on record since 2012-04-05. Other recent recalls include the 2017-04-21 Hospira Infant Dextrose Injection Recall for hair particulates, the 2016-11-01 Hospira Fentanyl Injection Recall for broken ampule tips, and the 2016-08-15 Hospira DOBUTamine Injection Recall for discoloration. Other recent recalls of similar products include the 2026-07-16 Fresenius Kabi Lidocaine HCl Injection Recall, the 2026-06-08 Asclemed Lidocaine HCl Injection Recall, and the 2026-04-02 Huons Co Lidocaine HCl Injection Recall.